Dr Wade R Smith, MD - Medicare Orthopedic Surgery in Englewood, CO

Dr Wade R Smith, MD is a medicare enrolled "Orthopaedic Surgery" physician in Englewood, Colorado. He went to University Of Cincinnati College Of Medicine and graduated in 1990 and has 34 years of diverse experience with area of expertise as Orthopedic Surgery. He is a member of the group practice Healthone Clinic Services - Orthopedic Specialists Llc and his current practice location is 701 E Hampden Ave, #515, Englewood, Colorado. You can reach out to his office (for appointments etc.) via phone at (303) 209-2503.

Dr Wade R Smith is licensed to practice in Colorado (license number 36792) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1790888691.

Contact Information

Dr Wade R Smith, MD
701 E Hampden Ave, #515,
Englewood, CO 80113-2736
(303) 209-2503
(303) 761-0803



Physician's Profile

Full NameDr Wade R Smith
GenderMale
SpecialityOrthopedic Surgery
Experience34 Years
Location701 E Hampden Ave, Englewood, Colorado
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Wade R Smith attended and graduated from University Of Cincinnati College Of Medicine in 1990
  NPI Data:
  • NPI Number: 1790888691
  • Provider Enumeration Date: 09/06/2006
  • Last Update Date: 01/27/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 8921056243
  • Enrollment ID: I20050104000303

Medical Identifiers

Medical identifiers for Dr Wade R Smith such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1790888691NPI-NPPES
10025942600MedicaidNE
1790888691MedicaidWY
18455573MedicaidCO

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207X00000XOrthopaedic Surgery MD048555L (Pennsylvania)Secondary
207X00000XOrthopaedic Surgery 36792 (Colorado)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Hca-healthone Dba Swedish Medical CenterEnglewood, COHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Healthone Clinic Services - Orthopedic Specialists Llc579997272551

News Archive

EPA continues to validate ToxCast screening tool by testing more than 100 drugs

The U.S. Environmental Protection Agency will continue validating its ToxCast screening tool by screening more than 100 drugs provided by Pfizer, GlaxoSmithKline, Sanofi-Aventis, and Merck. These drugs never entered the marketplace because they demonstrated different types and levels of toxicity when the pharmaceutical companies conducted the early stage clinical trials required by the Food and Drug Administration as part of the drug development process.

Lonafarnib proves effective for children with progeria

Results of the first-ever clinical drug trial for children with Progeria, a rare, fatal "rapid-aging" disease, demonstrate the efficacy of a farnesyltransferase inhibitor (FTI), a drug originally developed to treat cancer. The clinical trial results, completed only six years after scientists identified the cause of Progeria, included significant improvements in weight gain, bone structure and, most importantly, the cardiovascular system, according to The Progeria Research Foundation (PRF) and Boston Children's Hospital.

First mobile safety lab for South African patients with AIDS and TB

The first mobile safety laboratory to operate under Biosafety Level 3 has been in use in South Africa since May 2011. As development of the Fraunhofer Institute for Biomedical Engineering in St. Ingbert, this special truck is used for testing and advising patients with AIDS and tuberculosis. The mobile laboratory can save patients' lives in remote areas because it cuts the waiting time between diagnosis and the start of treatment to just one day.

Phase II clinical study results of Kamada's inhaled-AAT for cystic fibrosis presented at the ERS Congress

Kamada, a bio-pharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, announced that data on its next-generation alpha-1 antitrypsin (Inhaled-AAT) in cystic fibrosis patients was presented today, at the Annual Congress of the European Respiratory Society (ERS) 2009, Vienna. As previously reported, the study showed that inhaled-AAT was safe and biologically effective.

Read more Medical News

› Verified 6 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Wade R Smith allows following entities to bill medicare on his behalf.
Entity NameDenver Health And Hospital Authority
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1477569838
PECOS PAC ID: 4688583578
Enrollment ID: O20031105000211

News Archive

EPA continues to validate ToxCast screening tool by testing more than 100 drugs

The U.S. Environmental Protection Agency will continue validating its ToxCast screening tool by screening more than 100 drugs provided by Pfizer, GlaxoSmithKline, Sanofi-Aventis, and Merck. These drugs never entered the marketplace because they demonstrated different types and levels of toxicity when the pharmaceutical companies conducted the early stage clinical trials required by the Food and Drug Administration as part of the drug development process.

Lonafarnib proves effective for children with progeria

Results of the first-ever clinical drug trial for children with Progeria, a rare, fatal "rapid-aging" disease, demonstrate the efficacy of a farnesyltransferase inhibitor (FTI), a drug originally developed to treat cancer. The clinical trial results, completed only six years after scientists identified the cause of Progeria, included significant improvements in weight gain, bone structure and, most importantly, the cardiovascular system, according to The Progeria Research Foundation (PRF) and Boston Children's Hospital.

First mobile safety lab for South African patients with AIDS and TB

The first mobile safety laboratory to operate under Biosafety Level 3 has been in use in South Africa since May 2011. As development of the Fraunhofer Institute for Biomedical Engineering in St. Ingbert, this special truck is used for testing and advising patients with AIDS and tuberculosis. The mobile laboratory can save patients' lives in remote areas because it cuts the waiting time between diagnosis and the start of treatment to just one day.

Phase II clinical study results of Kamada's inhaled-AAT for cystic fibrosis presented at the ERS Congress

Kamada, a bio-pharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, announced that data on its next-generation alpha-1 antitrypsin (Inhaled-AAT) in cystic fibrosis patients was presented today, at the Annual Congress of the European Respiratory Society (ERS) 2009, Vienna. As previously reported, the study showed that inhaled-AAT was safe and biologically effective.

Read more Medical News

› Verified 6 days ago

Entity NameHealthone Clinic Services - Orthopedic Specialists Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1245556091
PECOS PAC ID: 5799972725
Enrollment ID: O20101203000060

News Archive

EPA continues to validate ToxCast screening tool by testing more than 100 drugs

The U.S. Environmental Protection Agency will continue validating its ToxCast screening tool by screening more than 100 drugs provided by Pfizer, GlaxoSmithKline, Sanofi-Aventis, and Merck. These drugs never entered the marketplace because they demonstrated different types and levels of toxicity when the pharmaceutical companies conducted the early stage clinical trials required by the Food and Drug Administration as part of the drug development process.

Lonafarnib proves effective for children with progeria

Results of the first-ever clinical drug trial for children with Progeria, a rare, fatal "rapid-aging" disease, demonstrate the efficacy of a farnesyltransferase inhibitor (FTI), a drug originally developed to treat cancer. The clinical trial results, completed only six years after scientists identified the cause of Progeria, included significant improvements in weight gain, bone structure and, most importantly, the cardiovascular system, according to The Progeria Research Foundation (PRF) and Boston Children's Hospital.

First mobile safety lab for South African patients with AIDS and TB

The first mobile safety laboratory to operate under Biosafety Level 3 has been in use in South Africa since May 2011. As development of the Fraunhofer Institute for Biomedical Engineering in St. Ingbert, this special truck is used for testing and advising patients with AIDS and tuberculosis. The mobile laboratory can save patients' lives in remote areas because it cuts the waiting time between diagnosis and the start of treatment to just one day.

Phase II clinical study results of Kamada's inhaled-AAT for cystic fibrosis presented at the ERS Congress

Kamada, a bio-pharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, announced that data on its next-generation alpha-1 antitrypsin (Inhaled-AAT) in cystic fibrosis patients was presented today, at the Annual Congress of the European Respiratory Society (ERS) 2009, Vienna. As previously reported, the study showed that inhaled-AAT was safe and biologically effective.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Wade R Smith is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Wade R Smith, MD
4900 S Monaco St, #210,
Denver, CO 80237-3486

Ph: (303) 209-2503
Dr Wade R Smith, MD
701 E Hampden Ave, #515,
Englewood, CO 80113-2736

Ph: (303) 209-2503

News Archive

EPA continues to validate ToxCast screening tool by testing more than 100 drugs

The U.S. Environmental Protection Agency will continue validating its ToxCast screening tool by screening more than 100 drugs provided by Pfizer, GlaxoSmithKline, Sanofi-Aventis, and Merck. These drugs never entered the marketplace because they demonstrated different types and levels of toxicity when the pharmaceutical companies conducted the early stage clinical trials required by the Food and Drug Administration as part of the drug development process.

Lonafarnib proves effective for children with progeria

Results of the first-ever clinical drug trial for children with Progeria, a rare, fatal "rapid-aging" disease, demonstrate the efficacy of a farnesyltransferase inhibitor (FTI), a drug originally developed to treat cancer. The clinical trial results, completed only six years after scientists identified the cause of Progeria, included significant improvements in weight gain, bone structure and, most importantly, the cardiovascular system, according to The Progeria Research Foundation (PRF) and Boston Children's Hospital.

First mobile safety lab for South African patients with AIDS and TB

The first mobile safety laboratory to operate under Biosafety Level 3 has been in use in South Africa since May 2011. As development of the Fraunhofer Institute for Biomedical Engineering in St. Ingbert, this special truck is used for testing and advising patients with AIDS and tuberculosis. The mobile laboratory can save patients' lives in remote areas because it cuts the waiting time between diagnosis and the start of treatment to just one day.

Phase II clinical study results of Kamada's inhaled-AAT for cystic fibrosis presented at the ERS Congress

Kamada, a bio-pharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, announced that data on its next-generation alpha-1 antitrypsin (Inhaled-AAT) in cystic fibrosis patients was presented today, at the Annual Congress of the European Respiratory Society (ERS) 2009, Vienna. As previously reported, the study showed that inhaled-AAT was safe and biologically effective.

Read more News

› Verified 6 days ago


Orthopaedic Surgery Doctors in Englewood, CO

Dr. Judith Emily Kopinski, MD
Orthopedic Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 145 Inverness Dr E Ste 300, Englewood, CO 80112
Phone: 303-695-6060    Fax: 303-369-7776
John S Woodward Jr., M.D.
Orthopedic Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 799 E Hampden Ave, Suite 400, Englewood, CO 80113
Phone: 303-789-2663    Fax: 303-788-4871
Dr. Christopher Rolf Johnson, MD
Orthopedic Surgery
Medicare: Medicare Enrolled
Practice Location: 145 Inverness Dr E Ste 100, Englewood, CO 80112
Phone: 303-697-7463    
Philip Heyman, MD
Orthopedic Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 601 E Hampden Ave, Suite 500, Englewood, CO 80113
Phone: 303-744-7078    Fax: 303-744-0248
Trevor Jordan Wait, M.D.
Orthopedic Surgery
Medicare: Medicare Enrolled
Practice Location: 175 Inverness Dr W, Englewood, CO 80112
Phone: 720-848-0000    
Dr. Steven J Morgan, MD
Orthopedic Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 701 E Hampden Ave, Suite 515, Englewood, CO 80113
Phone: 303-209-2503    Fax: 303-761-0803
James T Muffly, M.D.
Orthopedic Surgery
Medicare: Not Enrolled in Medicare
Practice Location: 799 E Hampden Ave, Ste 310, Englewood, CO 80113
Phone: 303-788-7840    Fax: 303-788-7839

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.